Last reviewed · How we verify

NCT04744766: MDE

Central Mammary Duct Excision; How to Improve the Outcome?

Completed NA Last updated 9 February 2021
What this trial tests

NA trial testing major duct excision in Duct Ectasia Breast in 130 participants. Completed in 27 January 2021.

Timeline
1 January 2018
Primary endpoint
31 December 2020
27 January 2021

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment130
Start date1 January 2018
Primary completion31 December 2020
Estimated completion27 January 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Eligibility, female only, with Duct Ectasia Breast or Benign Breast Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the study compares two surgical techniques in excision of the central duct system of the breast. known also as major duct excision

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04744766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing